Clinical Trials in Phoenix

Showing 2201-2220 of 16,646 trials

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

NCT06129240

Study LTI-401 is an open-label, multicenter study which will evaluate the safety and tolerability of LIQ861 in subjects who have WHO Group 1 \& 3 PH.

Pulmonary HypertensionInterstitial Lung Disease

Liquidia Technologies, Inc.80 participantsStarted Dec 2023

Phoenix, Arizona, United States • Fresno, California, United States • Los Angeles, California, United States +15 more locations

AVAILABLE< 1 mile

Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel

NCT06617572

The purpose of this expanded access protocol (EAP) is to provide controlled access to Afamitresgene autoleucel, suspension for intravenous infusion that does not meet the commercial release specification (NC afami-cel). This EAP will be conducted at authorized treatment centers where TECELRA® is being administered and where the EAP is approved to be conducted. Patients who are prescribed TECELRA® , sign the informed consent form, and meet all entry criteria will be eligible to participate in this protocol.

Synovial SarcomaMyxoid Liposarcoma

USWM CT, LLC

Phoenix, Arizona, United States • Stanford, California, United States • Jacksonville, Florida, United States +8 more locations

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel

Find Trials by Condition in Phoenix

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

His-Bundle Corrective Pacing in Heart Failure

The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer

Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib

An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer

Factors in Learning And Plasticity: Healthy Vision

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

Intermuscular Coherence as a Biomarker for ALS

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous (SC) Presentations

A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors

LINX Reflux Management System or Fundoplication Clinical Study in Patients With Hiatal Hernia >3 cm

A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer

Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis

A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism

Early Feasibility Study of the Supira System in Patients Undergoing HRPCI